Details
|
Millennium Pharmaceuticals, inc. is the company who engages in the development, researching, and commercialization of cardiovascular, inflammatory diseases as well as therapeutic products in the areas of cancer. The company was founded in 1993 and is located in Cambridge, Massachusetts. Millennium’s products include Velcade, used to treat myeloma, integrilin injection, which prevents the incidence of heart attacks death in patients with acute coronary syndrome as well for the treatment of patients undergoing percutaneous coronary intervention. The company’s clinical and preclinical drug candidates include mln1202 for treatment of rheumatoid arthritis, multiple sclerosis, mln02 for crohns disease, mln2704 for prostate cancer, mln8054 for solid tumor cancer, mln3897 for chronic inflammatory disease. Millennium has strategic alliances with Schering corporation, Aventis pharma, Ortho biotech products, lp, GlaxoSmithKline plc.
|
